Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Hings

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pathology, Research and Practice|May 10, 2006
Classic Kaposi's sarcoma presenting first with gastrointestinal tract involvement in a HIV-negative Inuit male--a case report and review of the literatureBrinda Balachandra, Ellen Tunitsky, Shaheenah Dawood, et al.
Saudi Medical Journal|December 17, 2008
Low-dose chemotherapy for extra-abdominal desmoid tumorMohammed L Al-Otaibi, Robert E Turcotte, Ingrid Hings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcomaVivien H C Bramwell, Donald Morris, D Scott Ernst, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pathology, Research and Practice|May 10, 2006
Classic Kaposi's sarcoma presenting first with gastrointestinal tract involvement in a HIV-negative Inuit male--a case report and review of the literatureBrinda Balachandra, Ellen Tunitsky, Shaheenah Dawood, et al.
Saudi Medical Journal|December 17, 2008
Low-dose chemotherapy for extra-abdominal desmoid tumorMohammed L Al-Otaibi, Robert E Turcotte, Ingrid Hings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcomaVivien H C Bramwell, Donald Morris, D Scott Ernst, et al.
Pageof 1